If you grew up in the late 1990s or early 2000s, you may have heard of coco puffs, which is a term used to denote the combination of cannabis and cocaine, usually rolled into a blunt and smoked. But does it actually do anything? And if so, what are the effects? Is it safe? Let’s take a closer look.
What are coco puffs?
As explained above, coco puffs (also referred to as cocoa puffs, chewys, or primos) is referring to a blunt, joint, or bowl laced with cocaine. Cocaine is a popular, yet risky, central nervous system stimulant made from the leaves of the coca plant, native to South America.
Initially, the term “coco puffs” was used to describe a cigarette whose end was dipped in coke, typically by dabbing the tip of the cigarette against the mirror, tray, or whatever else was used to do lines on in order to pick up the residual leftovers. Some people still use the phrase this way. However, a growing number of people are calling their coke laced weed, coco puffs now. Whenever I heard the term in my teen and early adult years, it was always in reference to cannabis and cocaine.
Since I no longer experiment with party drugs, I honestly can’t say how common the mixture is these days. During a quick reddit search I was able to find some subreddits analyzing whether it works or not, how it feels, best methods, etc. Most of these threads were older, some dating back 10 years, but I found a couple from within the last few years and one as recent as 7 months ago. So it does seem like this was a more popular topic of discussion around the time I knew it to be trending, but clearly people are still trying it.
Does it work?
Although cannabis and cocaine are both drugs that produce unique and noticeable highs, that doesn’t mean that “coco puffs” is the best method for consuming them together. It seems easy and convenient, but not all drugs are meant to be smoked.
Take shrooms for example… when you eat them, you get high, no ifs, ands, or buts about it. Plus, mushrooms and cannabis go great together. If you eat some mushrooms and smoke a nice blunt afterwards, I assure you, you’ll be on cloud nine. However, if you were to smoke magic mushrooms by grinding them up and mixing them in with your weed, you wouldn’t feel a thing because exposing shrooms to direct flame degrades most of the psilocybin in the plant. It can also expose the smoker to a possible fungal infection.
The same goes for cocaine. Powder cocaine will burn before it vaporizes, so smoking it will have very little (if any) effect at all. People who want to smoke cocaine cannot do so with the HCl Salt, so they convert it to a freebase form, otherwise known as crack which is much more dangerous and addictive (seriously, don’t smoke crack). So, mixing cocaine with your weed is basically just a very expensive waste of time.
Can person get high by the placebo effect?
Although many swear that they do feel some effects from the popular combo, they’re most likely just psychosomatic. A psychosomatic condition is one that is characterized by the occurrence of physical symptoms lacking a medical explanation or root cause.
There are quite a few situations in which a person can experience psychosomatic symptoms. At one end of the spectrum, we have hypochondria, a well-documented disorder in which a long-term and intense fear of having a serious health problem can lead to the onset of physical symptoms. At the other end of the spectrum, we have the placebo effect, when a person’s physical or mental health seems to improve after taking a placebo or ‘dummy’ treatment.
Thank you for stopping in. Head over to the Cannadelics Weekly Newsletter for direct updates; and get access to awesome deals on cannabis buds, vapes, edibles, smoking devices and equipment, cannabinoid compounds, and some psychedelic products! Go get high responsibly!
Discussions of the placebo effect are usually in the context of medical treatments, but it can certainly apply to recreational drugs as well. There have been several famous experiments in psychology where control groups have shown symptoms of being drunk after taking a placebo because they believed they actually drank alcohol.
As a matter of fact, a study from McGill University published just a couple of years ago in Psychopharmacology suggests that, in certain situations, some people can even experience hallucinations and other “psychedelic-like effects” from placebos alone. In their research, a total of 61% of participants reported some “effect on the consciousness” after consuming the placebo.
Final thoughts
Inside the human mind is a beautiful and complicated place. It’s crazy to think that our brains can make us sick, heal us, and even get us high, but it is possible, and that seems to be what’s happening in the case of this strange, fluctuating trend. To sum it up, mixing cannabis and cocaine is pointless. But if you’re intent on combining cannabis and cocaine in some way (although we’re not condoning it, once again, cocaine is dangerous and addictive), your best bet is pass on the coco puffs and just use them separately.
Thanks for making your way over! We appreciate you stopping in at Cannadelics.com; where we work to bring you the best in independent news coverage for the cannabis and psychedelics spaces. Visit us regularly for daily news, and sign up to the Cannadelics Weekly Newsletter, so you’re always on top of what’s going on.
Part of the cannabis industry supported the new president, betting he was going to move and move quickly on cannabis – the White House finally commented.
The cannabis industry has been a boon for consumers, medical patients, veterans and legal states, but for the thousands of mom and pop businesses is has been a roller coaster. With a huge demand, it would seem to be easy money, but the federal, tax, and banking restrictions have made it difficult to grow and expand. Part of the industry were all for the new administration assuming they would support positive change, but many in the new cabinet and the House Speaker Mike Johnson are foes. Now the White House finally comments on marijuana industry…and it doesn’t show a clear path.
The administration’s current stance on marijuana reform is marked by inaction, despite campaign promises and earlier signals of support for cannabis-related reforms. A White House official recently confirmed that “no action is being considered at this time” regarding marijuana policy, leaving advocates and industry stakeholders uncertain about the administration’s priorities.
During his campaign, the resident expressed support for rescheduling marijuana under the Controlled Substances Act (CSA), which would move it from Schedule I to Schedule III, easing restrictions on medical use and enabling cannabis businesses to access banking and tax benefits. However, since taking office, no concrete steps have been taken to advance this initiative. A DEA hearing on rescheduling, initially planned for January 2025, was postponed due to procedural appeals and remains unscheduled.
The president has also voiced support for state autonomy in cannabis policy and endorsed state-level legalization initiatives, such as Florida’s failed 2024 ballot measure for recreational marijuana. While this reflects a more favorable stance compared to his first term, his administration has yet to prioritize federal reforms like the SAFE Banking Act, which would facilitate banking services for cannabis businesses. Efforts to include such measures in a government funding bill late last year were unsuccessful.
The delay in federal action has significant implications for the cannabis industry. Rescheduling marijuana could alleviate financial burdens by eliminating restrictions under IRS Code Section 280E and promoting medical research. However, the stalled process leaves businesses navigating regulatory uncertainties and limited financial access.
While stakeholders continue lobbying for reform, the administration appears focused on other priorities such as immigration and foreign policy. Advocates hope the President will leverage his influence to advance cannabis reform, but for now, the issue remains sidelined. Until then the industry struggles and waits.
States are starting to scramble with looming budget deficients, but marijuana is a boon to some – especially one state.
The new federal administration is revamping how the government operates. With Doge, they are changing agencies and reducing services and support of states, which has left budget deficients in many. But some states have legal marijana and it has been a boon, for like alcohol…people are still consuming. States who are fully legal are making more money on weed than booze and this state’s cannabis revenue keeps pouring in. Missouri, the show me state, is being shown unexpected revenue.
“Due to a strong cannabis market and effective, efficient regulation of that market,” Amy Moore, director of the Missouri Division of Cannabis Regulation, told The Independent this week, “the funds available for the ultimate beneficiaries of the cannabis regulatory program continue to outpace expectations.”
Funds will help veterans and other key projects. The other benefit is as seen in data from legal states, teen use is down so it frees up some other funds. Legal states are seeing benefits from legal cannabis including lower teen use and crime reduction.
States with legal cannabis are experiencing a significant boost in tax revenue, surpassing those generated by alcohol sales. This trend highlights the economic benefits of marijuana legalization, as cannabis markets expand and mature.
In California, cannabis excise taxes have consistently outperformed alcohol-related taxes, bringing in over double the revenue. Colorado has seen even more striking results, with marijuana tax revenues totaling seven times those of alcohol. Similarly, Massachusetts has collected more tax revenue from marijuana than alcohol since fiscal year 2021, marking a notable shift in state finances.
Nationally, legal cannabis states generated nearly $3 billion in excise taxes on marijuana in 2021—20% more than alcohol taxes. By 2024, total adult-use cannabis tax revenue exceeded $20 billion, with states like Illinois and Washington reporting record-breaking contributions. Illinois alone collected $451.9 million from cannabis taxes in fiscal year 2022—one-and-a-half times the revenue from alcohol.
The funds are being put to good use. States like Illinois are channeling marijuana tax dollars into mental health services and community programs, while Colorado has invested nearly $500 million into public education. California has allocated millions to nonprofits addressing the impacts of the war on drugs.
This growing revenue stream underscores the potential of cannabis legalization to support vital public services and bolster state economies. As more states embrace regulated marijuana markets, the financial benefits are expected to continue flourishing.
The federal administration is all over the board around fed cannabis policy…and millions of patients are worried.
The industry employees over 440,000 workers at all lives and is driven in a large part by mom and pop businesses. Millions use medical marijuana for health issues ranging from chronic pain to sleep. But there are mixed messages from the feds about cannabis, and people are very worried. The federal government’s stance on marijuana has become increasingly complex, as recent developments show conflicting approaches to the drug’s potential benefits and risks. On one hand, there’s a push for research into medical marijuana for veterans, while on the other, a campaign against cannabis use is being launched.
The juxtaposition of initiatives highlights the federal government’s inconsistent approach to marijuana policy. While some departments are exploring the potential benefits of cannabis, others are actively working to discourage its use. This dichotomy is further exemplified by ongoing legislative efforts. For instance, Rep. Brian Mast (R-FL) has reintroduced the Veterans Equal Access Act, which would allow VA doctors to recommend medical marijuana to patients in states where it’s legal. Meanwhile, documents from an ongoing lawsuit suggest that the DEA may have weighted the marijuana rescheduling process to ensure rejection of moving the drug from Schedule 1 to Schedule 3.
Photo by yavdat/Getty Images
The Department of Defense (DOD) has allocated nearly $10 million in funding for research into the therapeutic potential of MDMA for active-duty military members. This initiative, driven by congressional efforts, aims to explore MDMA’s effectiveness in treating conditions such as post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI). Rep. Morgan Luttrell (R-TX) expressed pride in this development, stating that it could be a “game-changer” for service members battling these combat-related injuries.
Additionally, a bipartisan effort in Congress has been pushing for VA research on medical marijuana for PTSD and other conditions affecting veterans. The VA Medicinal Cannabis Research Act, introduced in both the Senate and House, would mandate studies on how cannabis affects the use of addictive medications and impacts various health outcomes for veterans.
In stark contrast to these research initiatives, the Drug Enforcement Administration (DEA) has partnered with an anti-cannabis nonprofit to launch a social media campaign targeting young people. The campaign, set to run ahead of April 20 (4/20), aims to “flood” Instagram with anti-cannabis content. The DEA is offering monetary incentives to students for creating and posting anti-THC videos, with payments ranging from $25 to $50 depending on the type of content produced.
This approach has raised eyebrows, as it seems to contradict the growing acceptance and legalization of marijuana across the United States. Critics argue that such campaigns may be out of touch with current societal trends and scientific understanding of cannabis.